Julius Few, MD, a plastic surgeon and founder of The Few Institute in Chicago, noticed his facelift patients who were on GLP-1s had skin like worn-out rubber bands or old putty, his words
The inclusion of these variables played a crucial role in controlling confounding factors within our study
the study's lead author and a professor of radiology in the University of Pennsylvania Perelman School of Medicine, said in a statement that the findings were "observational" and do not "definitively confirm an association between GLP-1 medications and reduced breast cancer incidence," however the study "does add to the growing body of evidence suggesting that it's worth investigating these weight-loss drugs as potential cancer prevention tools." Narula reiterated that the new study is "hypothesis-generating" not "practice-changing," though the study does add to a growing body of similar research
29 patients received pregabalin at the standard dose of 150 mg three times a day (arm B)
The methylation cycle is an important part of glutathione production
Novo Nordisk would not comment on the new pharmacy benefits arrangements
